Inventor · disambiguated record
Lu Huang
Also filed as: HUANG LU · HUANG LU-SHIANG
23 granted patents·11 pending applications·120 citations·filing 1998–2023
94Inventor score
Files withNOVARTIS AG17HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC5HUMANWELL HEALTHCARE GROUP CO LTD3BRIGHTGENE BIO MEDICAL TECH CO LTD1CHEN YONGSHENG1
Top patents by PatentIndex Score
34 records- 0196US10525083B2Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2017·Granted Jan 7, 2020·15 cites·33 claims
- 0296US10253086B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2016·Granted Apr 9, 2019·37 cites·35 claims
- 0394US11149076B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2019·Granted Oct 19, 2021·9 cites·32 claims
- 0494US11026976B2Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2019·Granted Jun 8, 2021·6 cites·23 claims
- 0593US12275795B2Binding molecules against BCMA and uses thereofNOVARTIS AG·Filed 2022·Granted Apr 15, 2025·2 cites·23 claims
- 0693US11872249B2Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domainNOVARTIS AG·Filed 2021·Granted Jan 16, 2024·2 cites·38 claims
- 0793US11492409B2Binding molecules against BCMA and uses thereofNOVARTIS AG·Filed 2019·Granted Nov 8, 2022·10 cites·26 claims
- 0890US11608382B2BCMA chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2019·Granted Mar 21, 2023·4 cites·27 claims
- 0989US12344657B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2021·Granted Jul 1, 2025·1 cites·27 claims
- 1081US11952428B2BCMA chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2023·Granted Apr 9, 2024·0 cites·17 claims
- 1181US11939389B2BCMA chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2023·Granted Mar 26, 2024·0 cites·90 claims
- 1280US12383601B2Chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2020·Granted Aug 12, 2025·1 cites·21 claims
- 1380US2023374105A1Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car)-expressing cellNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1479USRE49847ENucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2022·Granted Feb 27, 2024·0 cites·35 claims
- 1577US2023416390A1Bcma chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1674USD991320SLaser projectorSHENZHEN LUBON TECH CO LTD·Filed 2021·Granted Jul 4, 2023·8 cites·1 claims
- 1774US10662174B2BTK inhibitorHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2017·Granted May 26, 2020·1 cites·8 claims
- 1872US9856262B2Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitorsHUBEI BIO-PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2015·Granted Jan 2, 2018·2 cites·21 claims
- 1969US10428073B2Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2016·Granted Oct 1, 2019·1 cites·13 claims
- 2066US10941150B2Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2019·Granted Mar 9, 2021·0 cites·12 claims
- 2164US8350065B25,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the sameGRAND PHARMA CHINA CO LTD·Filed 2009·Granted Jan 8, 2013·1 cites·8 claims
- 2255US6080658ADevice protection structure for preventing plasma charging damage and vertical cross talkUNITED MICROELECTRONICS CORP·Filed 1998·Granted Jun 27, 2000·20 cites·6 claims
- 2354US11965920B1Method for achieving terminal-pair definition of four-terminal-pair impedance and application thereofNAT INST METROLOGY CHINA·Filed 2023·Granted Apr 23, 2024·0 cites·3 claims
- 2450US2022332821A1Dosing regimen and combination therapies for multispecific antibodies targeting b-cell maturation antigenNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2550US2024282765A1Ggnmos transistor structure, esd protection device and circuitCSMC TECHNOLOGIES FAB2 CO LTD·Filed 2022·Application pending·0 cites
- 2648US2022396631A1Trispecific binding molecules against bcma and uses thereofHUANG LU·Filed 2020·Application pending·0 cites
- 2747US10695347B2Pyrimidine derivative and use thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2016·Granted Jun 30, 2020·0 cites·20 claims
- 2845US2022064141A1Benzopyridone heterocyclic compound and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 2944US2022364055A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3040US2016303178A1Pharmaceutical composition, method for preparing the same and use thereofHUMANWELL HEALTHCARE (GROUP) CO LTD·Filed 2014·Application pending·0 cites
- 3140US2017028007A1Solid dispersion containing desmodium styracifolium (osb.) merr. flavonoids, method of preparing same, and use thereofHUMANWELL HEALTHCARE (GROUP) CO LTD·Filed 2014·Application pending·0 cites
- 3239US2012012796A1Conductive films based on graphene and process for preparing the sameCHEN YONGSHENG·Filed 2010·Application pending·0 cites
- 3335US2005072975A1Partially depleted soi mosfet deviceFiled 2003·Application pending·0 cites
- 3432US9724374B2Capsule containing total flavonoids of desmodium styracifolium, method for preparing the same and useHUMANWELL HEALTHCARE (GROUP) CO LTD·Filed 2014·Granted Aug 8, 2017·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Lu Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →